{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T08:41:31Z","timestamp":1762936891924,"version":"3.45.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":8,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002383","name":"King Saud University","doi-asserted-by":"publisher","award":["RSP2024R490"],"award-info":[{"award-number":["RSP2024R490"]}],"id":[{"id":"10.13039\/501100002383","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Saudi Pharm. J."],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s44446-025-00032-4","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T14:51:50Z","timestamp":1760021510000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Acidifying agents impact erlotinib and gefitinib pharmacokinetic parameters and elevate liver enzymes in Wistar rats"],"prefix":"10.1007","volume":"33","author":[{"given":"Amsha S.","family":"Alsegiani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0181-6330","authenticated-orcid":false,"given":"Aliyah","family":"Almomen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Arafah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nourah Z.","family":"Alzoman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah","family":"K.Alshememry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,9]]},"reference":[{"key":"32_CR1","doi-asserted-by":"publisher","unstructured":"Abuduli M, Ohminami H, Otani T, Kubo H, Ueda H, Kawai Y,... Taketani Y (2016) Effects of dietary phosphate on glucose and lipid metabolism. Am J Physiol Endocrinol Metab, 310(7), E526\u2013538. https:\/\/doi.org\/10.1152\/ajpendo.00234.2015","DOI":"10.1152\/ajpendo.00234.2015"},{"issue":"1","key":"32_CR2","doi-asserted-by":"publisher","first-page":"LMT43","DOI":"10.2217\/lmt-2020-0011","volume":"10","author":"A Alanazi","year":"2020","unstructured":"Alanazi A, Yunusa I, Elenizi K, Alzarea AI (2020) Efficacy and safety of tyrosine kinase inhibitors in advanced non-small-cell lung cancer harboring epidermal growth factor receptor mutation: a network meta-analysis. Lung Cancer Manag 10(1):LMT43. https:\/\/doi.org\/10.2217\/lmt-2020-0011","journal-title":"Lung Cancer Manag"},{"key":"32_CR3","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.9881","volume":"8","author":"A Almomen","year":"2020","unstructured":"Almomen A, Maher HM, Alzoman NZ, Shehata SM, Alsubaie A (2020) Flavoured water consumption alters pharmacokinetic parameters and increases exposure of erlotinib and gefitinib in a preclinical study using Wistar rats. PeerJ 8:e9881. https:\/\/doi.org\/10.7717\/peerj.9881","journal-title":"PeerJ"},{"key":"32_CR4","doi-asserted-by":"publisher","unstructured":"AlRasheed H, Almomen A, Aljohar HI, Arafah M, Almotawa RY, Alossaimi MA, & Alzoman NZ (2022) Aspartames Alter Pharmacokinetics Parameters of Erlotinib and Gefitinib and Elevate Liver Enzymes in Wistar Rats. Pharmaceuticals (Basel), 15(11). https:\/\/doi.org\/10.3390\/ph15111400","DOI":"10.3390\/ph15111400"},{"key":"32_CR5","doi-asserted-by":"publisher","unstructured":"Arnold BN, Thomas DC, Rosen JE, Salazar MC, Blasberg JD, Boffa DJ,... Kim AW (2016) Lung Cancer in the Very Young: Treatment and Survival in the National Cancer Data Base. J Thorac Oncol, 11(7), 1121\u20131131. https:\/\/doi.org\/10.1016\/j.jtho.2016.03.023","DOI":"10.1016\/j.jtho.2016.03.023"},{"issue":"12","key":"32_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/nutd.2015.38","volume":"5","author":"JJ Ayoub","year":"2015","unstructured":"Ayoub JJ, Samra MJ, Hlais SA, Bassil MS, Obeid OA (2015) Effect of phosphorus supplementation on weight gain and waist circumference of overweight\/obese adults: a randomized clinical trial. Nutr Diabetes 5(12):e189. https:\/\/doi.org\/10.1038\/nutd.2015.38","journal-title":"Nutr Diabetes"},{"key":"32_CR7","doi-asserted-by":"publisher","unstructured":"Blais EM, Rawls KD, Dougherty BV, Li ZI, Kolling GL, Ye P,... Papin JA (2017) Reconciled rat and human metabolic networks for comparative toxicogenomics and biomarker predictions. Nat Commun, 8, 14250. https:\/\/doi.org\/10.1038\/ncomms14250","DOI":"10.1038\/ncomms14250"},{"key":"32_CR8","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/B978-0-12-384947-2.00304-4","volume-title":"Encyclopedia of Food and Health","author":"GA Blekas","year":"2016","unstructured":"Blekas GA (2016) Food Additives: Classification, Uses and Regulation. In: Caballero B, Finglas PM, Toldr\u00e1 F (eds) Encyclopedia of Food and Health. Academic Press, Oxford, pp 731\u2013736"},{"key":"32_CR9","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1007\/978-3-030-84860-6_87","volume-title":"The ADME Encyclopedia","author":"P Butler","year":"2022","unstructured":"Butler P, Riley RJ (2022) Drug-Drug and Food-Drug Interactions. In: Talevi A (ed) The ADME Encyclopedia. Springer International Publishing, Cham, pp 448\u2013456"},{"issue":"2","key":"32_CR10","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s10616-013-9567-1","volume":"66","author":"X Chen","year":"2014","unstructured":"Chen X, Lv Q, Liu Y, Deng W (2014) Study on injury effect of food additive citric acid on liver tissue in mice. Cytotechnology 66(2):275\u2013282. https:\/\/doi.org\/10.1007\/s10616-013-9567-1","journal-title":"Cytotechnology"},{"issue":"1","key":"32_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15280\/jlm.2017.7.1.1","volume":"7","author":"JH Choi","year":"2017","unstructured":"Choi JH, Ko CM (2017) Food and Drug Interactions. J Lifestyle Med 7(1):1\u20139. https:\/\/doi.org\/10.15280\/jlm.2017.7.1.1","journal-title":"J Lifestyle Med"},{"issue":"5","key":"32_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0155386","volume":"11","author":"S Chun","year":"2016","unstructured":"Chun S, Bamba T, Suyama T, Ishijima T, Fukusaki E, Abe K, Nakai Y (2016) A High Phosphorus Diet Affects Lipid Metabolism in Rat Liver: A DNA Microarray Analysis. PLoS ONE 11(5):e0155386. https:\/\/doi.org\/10.1371\/journal.pone.0155386","journal-title":"PLoS ONE"},{"issue":"13","key":"32_CR13","doi-asserted-by":"publisher","first-page":"4686","DOI":"10.1002\/cam4.3064","volume":"9","author":"P Cotogni","year":"2020","unstructured":"Cotogni P, Monge T, Passera R, Brossa L, De Francesco A (2020) Clinical characteristics and predictive factors of survival of 761 cancer patients on home parenteral nutrition: A prospective, cohort study. Cancer Med 9(13):4686\u20134698. https:\/\/doi.org\/10.1002\/cam4.3064","journal-title":"Cancer Med"},{"key":"32_CR14","doi-asserted-by":"publisher","unstructured":"Gibbs RA, Weinstock GM, Metzker ML, Muzny DM, Sodergren EJ, Scherer S,... Rat Genome Sequencing Project C (2004) Genome sequence of the Brown Norway rat yields insights into mammalian evolution. Nature, 428(6982), 493\u2013521. https:\/\/doi.org\/10.1038\/nature02426","DOI":"10.1038\/nature02426"},{"key":"32_CR15","doi-asserted-by":"publisher","unstructured":"Ionescu C, Caira MR (2005) Drug metabolism in context (prevajalec, Trans.). In: Ionescu C, Caira MR (eds) Drug metabolism. Springer Netherlands, pp 1\u201340. https:\/\/doi.org\/10.1007\/1-4020-4142-x_1","DOI":"10.1007\/1-4020-4142-x_1"},{"issue":"5","key":"32_CR16","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1097\/FTD.0b013e318292b931","volume":"35","author":"DH Josephs","year":"2013","unstructured":"Josephs DH, Fisher DS, Spicer J, Flanagan RJ (2013) Clinical pharmacokinetics of tyrosine kinase inhibitors: implications for therapeutic drug monitoring. Ther Drug Monit 35(5):562\u2013587. https:\/\/doi.org\/10.1097\/FTD.0b013e318292b931","journal-title":"Ther Drug Monit"},{"key":"32_CR17","doi-asserted-by":"publisher","unstructured":"Kijima T, Shimizu T, Nonen S, Furukawa M, Otani Y, Minami T,... Kawase I (2011) Safe and successful treatment with erlotinib after gefitinib-induced hepatotoxicity: difference in metabolism as a possible mechanism. J Clin Oncol, 29(19), e588\u2013590. https:\/\/doi.org\/10.1200\/JCO.2010.34.3368","DOI":"10.1200\/JCO.2010.34.3368"},{"key":"32_CR18","doi-asserted-by":"publisher","unstructured":"Kizub DA, Raber M, Baum M, Ma HY, Patel TA, Rechis R,... Basen-Engquist K (2025) Patient and Health Care Professional Perspectives on Barriers to and Facilitators of Healthy Eating and Exercise Among Patients With Cancer at a Safety-Net Oncology Clinic: A Qualitative Exploration. JCO Oncol Pract, OP2400431. https:\/\/doi.org\/10.1200\/OP.24.00431","DOI":"10.1200\/OP.24.00431"},{"issue":"5","key":"32_CR19","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1097\/CAD.0000000000000212","volume":"26","author":"H Kletzl","year":"2015","unstructured":"Kletzl H, Giraudon M, Ducray PS, Abt M, Hamilton M, Lum BL (2015) Effect of gastric pH on erlotinib pharmacokinetics in healthy individuals: omeprazole and ranitidine. Anticancer Drugs 26(5):565\u2013572. https:\/\/doi.org\/10.1097\/CAD.0000000000000212","journal-title":"Anticancer Drugs"},{"key":"32_CR20","doi-asserted-by":"publisher","unstructured":"Kumarakulasinghe NB, Syn N, Soon YY, Asmat A, Zheng H, Loy, EY,... Soo RA (2016) EGFR kinase inhibitors and gastric acid suppressants in EGFR-mutant NSCLC: a retrospective database analysis of potential drug interaction. Oncotarget, 7(51), 85542\u201385550. https:\/\/doi.org\/10.18632\/oncotarget.13458","DOI":"10.18632\/oncotarget.13458"},{"issue":"Suppl 2","key":"32_CR21","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1038\/modpathol.3801018","volume":"21","author":"M Ladanyi","year":"2008","unstructured":"Ladanyi M, Pao W (2008) Lung adenocarcinoma: guiding EGFR-targeted therapy and beyond. Mod Pathol 21(Suppl 2):S16-22. https:\/\/doi.org\/10.1038\/modpathol.3801018","journal-title":"Mod Pathol"},{"key":"32_CR22","doi-asserted-by":"publisher","unstructured":"Lambros M, Tran TH, Fei Q, Nicolaou M (2022) Citric acid: a multifunctional pharmaceutical excipient. Pharmaceutics 14(5). https:\/\/doi.org\/10.3390\/pharmaceutics14050972","DOI":"10.3390\/pharmaceutics14050972"},{"key":"32_CR23","doi-asserted-by":"publisher","unstructured":"Larkin PJ, Cherny NI, La Carpia D, Guglielmo M, Ostgathe C, Scotte F,... Committee EG (2018) Diagnosis, assessment and management of constipation in advanced cancer: ESMO Clinical Practice Guidelines. Ann Oncol, 29(Suppl 4), iv111-iv125. https:\/\/doi.org\/10.1093\/annonc\/mdy148","DOI":"10.1093\/annonc\/mdy148"},{"key":"32_CR24","doi-asserted-by":"publisher","unstructured":"van Leeuwen RW, Peric R, Hussaarts KG, Kienhuis E, NS IJ, de Bruijn P,... Mathijssen RH (2016) Influence of the Acidic Beverage Cola on the Absorption of Erlotinib in Patients With Non-Small-Cell Lung Cancer. J Clin Oncol, 34(12), 1309\u20131314. https:\/\/doi.org\/10.1200\/JCO.2015.65.2560","DOI":"10.1200\/JCO.2015.65.2560"},{"key":"32_CR25","doi-asserted-by":"publisher","unstructured":"van Leeuwen RWF, Jansman FGA, Hunfeld NG, Peric R, Reyners AKL, Imholz ALT,... Mathijssen RHJ (2017) Tyrosine Kinase Inhibitors and Proton Pump Inhibitors: An Evaluation of Treatment Options. Clin Pharmacokinet, 56(7), 683\u2013688. https:\/\/doi.org\/10.1007\/s40262-016-0503-3","DOI":"10.1007\/s40262-016-0503-3"},{"issue":"12","key":"32_CR26","doi-asserted-by":"publisher","first-page":"3731","DOI":"10.1158\/1078-0432.CCR-07-0088","volume":"13","author":"J Li","year":"2007","unstructured":"Li J, Zhao M, He P, Hidalgo M, Baker SD (2007) Differential metabolism of gefitinib and erlotinib by human cytochrome P450 enzymes. Clin Cancer Res 13(12):3731\u20133737. https:\/\/doi.org\/10.1158\/1078-0432.CCR-07-0088","journal-title":"Clin Cancer Res"},{"key":"32_CR27","doi-asserted-by":"publisher","unstructured":"Li J, Wang L, Han M, Xiong Y, Liao R, Li Y,... Su B (2019) The role of phosphate-containing medications and low dietary phosphorus-protein ratio in reducing intestinal phosphorus load in patients with chronic kidney disease. Nutr Diabetes, 9(1), 14. https:\/\/doi.org\/10.1038\/s41387-019-0080-2","DOI":"10.1038\/s41387-019-0080-2"},{"issue":"2","key":"32_CR28","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1097\/CAD.0b013e3282f2d8e4","volume":"19","author":"J Ling","year":"2008","unstructured":"Ling J, Fettner S, Lum BL, Riek M, Rakhit A (2008) Effect of food on the pharmacokinetics of erlotinib, an orally active epidermal growth factor receptor tyrosine-kinase inhibitor, in healthy individuals. Anticancer Drugs 19(2):209\u2013216. https:\/\/doi.org\/10.1097\/CAD.0b013e3282f2d8e4","journal-title":"Anticancer Drugs"},{"key":"32_CR29","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jpba.2016.03.013","volume":"124","author":"HM Maher","year":"2016","unstructured":"Maher HM, Alzoman NZ, Shehata SM (2016) Simultaneous determination of selected tyrosine kinase inhibitors with corticosteroids and antiemetics in rat plasma by solid phase extraction and ultra-performance liquid chromatography-tandem mass spectrometry: Application to pharmacokinetic interaction studies. J Pharm Biomed Anal 124:216\u2013227. https:\/\/doi.org\/10.1016\/j.jpba.2016.03.013","journal-title":"J Pharm Biomed Anal"},{"issue":"3","key":"32_CR30","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1053\/j.seminoncol.2019.08.004","volume":"46","author":"A Masood","year":"2019","unstructured":"Masood A, Kancha RK, Subramanian J (2019) Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in non-small cell lung cancer harboring uncommon EGFR mutations: Focus on afatinib. Semin Oncol 46(3):271\u2013283. https:\/\/doi.org\/10.1053\/j.seminoncol.2019.08.004","journal-title":"Semin Oncol"},{"issue":"11","key":"32_CR31","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.32604\/or.2024.053972","volume":"32","author":"SR Modi","year":"2024","unstructured":"Modi SR, Andey T (2024) Piperlongumine in combination with EGFR tyrosine kinase inhibitors for the treatment of lung cancer cells. Oncol Res 32(11):1709\u20131721. https:\/\/doi.org\/10.32604\/or.2024.053972","journal-title":"Oncol Res"},{"issue":"11","key":"32_CR32","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1016\/s0271-5317(99)00117-7","volume":"19","author":"J Ohdachi","year":"1999","unstructured":"Ohdachi J, Masuyama R, Uehara M, Kanke Y, Goto S, Suzuki K (1999) Change in protein synthesis in rats fed a high phosphorus diet. Nutr Res 19(11):1625\u20131635. https:\/\/doi.org\/10.1016\/s0271-5317(99)00117-7","journal-title":"Nutr Res"},{"key":"32_CR33","unstructured":"Palleria C, Di Paolo A, Giofre C, Caglioti C, Leuzzi G, Siniscalchi A,... Gallelli L (2013) Pharmacokinetic drug-drug interaction and their implication in clinical management. J Res Med Sci, 18(7), 601\u2013610. Retrieved from https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24516494"},{"issue":"4","key":"32_CR34","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s40262-019-00844-3","volume":"59","author":"D Patel","year":"2020","unstructured":"Patel D, Bertz R, Ren S, Boulton DW, Nagard M (2020) A Systematic Review of Gastric Acid-Reducing Agent-Mediated Drug-Drug Interactions with Orally Administered Medications. Clin Pharmacokinet 59(4):447\u2013462. https:\/\/doi.org\/10.1007\/s40262-019-00844-3","journal-title":"Clin Pharmacokinet"},{"issue":"8","key":"32_CR35","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.ctrv.2014.06.010","volume":"40","author":"S Peters","year":"2014","unstructured":"Peters S, Zimmermann S, Adjei AA (2014) Oral epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small cell lung cancer: comparative pharmacokinetics and drug-drug interactions. Cancer Treat Rev 40(8):917\u2013926. https:\/\/doi.org\/10.1016\/j.ctrv.2014.06.010","journal-title":"Cancer Treat Rev"},{"issue":"3","key":"32_CR36","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","volume":"22","author":"S Reagan-Shaw","year":"2008","unstructured":"Reagan-Shaw S, Nihal M, Ahmad N (2008) Dose translation from animal to human studies revisited. Faseb j 22(3):659\u2013661. https:\/\/doi.org\/10.1096\/fj.07-9574LSF","journal-title":"Faseb j"},{"issue":"4","key":"32_CR37","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3238\/arztebl.2012.0049","volume":"109","author":"E Ritz","year":"2012","unstructured":"Ritz E, Hahn K, Ketteler M, Kuhlmann MK, Mann J (2012) Phosphate additives in food\u2013a health risk. Dtsch Arztebl Int 109(4):49\u201355. https:\/\/doi.org\/10.3238\/arztebl.2012.0049","journal-title":"Dtsch Arztebl Int"},{"issue":"5\u20136","key":"32_CR38","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3727\/000000003783992289","volume":"11","author":"S Roy","year":"2004","unstructured":"Roy S, Rink C, Khanna S, Phillips C, Bagchi D, Bagchi M, Sen CK (2004) Body weight and abdominal fat gene expression profile in response to a novel hydroxycitric acid-based dietary supplement. Gene Expr 11(5\u20136):251\u2013262. https:\/\/doi.org\/10.3727\/000000003783992289","journal-title":"Gene Expr"},{"issue":"10","key":"32_CR39","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/BF02975428","volume":"27","author":"R Saleem","year":"2004","unstructured":"Saleem R, Ahmad M, Naz A, Siddiqui H, Ahmad SI, Faizi S (2004) Hypotensive and toxicological study of citric acid and other constituents from Tagetes patula roots. Arch Pharm Res 27(10):1037\u20131042. https:\/\/doi.org\/10.1007\/BF02975428","journal-title":"Arch Pharm Res"},{"issue":"7","key":"32_CR40","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s40264-013-0048-4","volume":"36","author":"RR Shah","year":"2013","unstructured":"Shah RR, Morganroth J, Shah DR (2013) Hepatotoxicity of tyrosine kinase inhibitors: clinical and regulatory perspectives. Drug Saf 36(7):491\u2013503. https:\/\/doi.org\/10.1007\/s40264-013-0048-4","journal-title":"Drug Saf"},{"key":"32_CR41","doi-asserted-by":"publisher","unstructured":"Song KH, Suh WS, Jeong JS, Kim DS, Kim SW, Kwak DM,... Shon DH (2014) Effectiveness of Sodium Picosulfate\/Magnesium Citrate (PICO) for Colonoscopy Preparation. Ann Coloproctol, 30(5), 222\u2013227. https:\/\/doi.org\/10.3393\/ac.2014.30.5.222","DOI":"10.3393\/ac.2014.30.5.222"},{"issue":"10","key":"32_CR42","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/nrc2190","volume":"7","author":"S Sun","year":"2007","unstructured":"Sun S, Schiller JH, Gazdar AF (2007) Lung cancer in never smokers\u2013a different disease. Nat Rev Cancer 7(10):778\u2013790. https:\/\/doi.org\/10.1038\/nrc2190","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"32_CR43","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2165\/00003088-200140040-00005","volume":"40","author":"H Swaisland","year":"2001","unstructured":"Swaisland H, Laight A, Stafford L, Jones H, Morris C, Dane A, Yates R (2001) Pharmacokinetics and tolerability of the orally active selective epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in healthy volunteers. Clin Pharmacokinet 40(4):297\u2013306. https:\/\/doi.org\/10.2165\/00003088-200140040-00005","journal-title":"Clin Pharmacokinet"},{"issue":"11","key":"32_CR44","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.2165\/00003088-200544110-00004","volume":"44","author":"HC Swaisland","year":"2005","unstructured":"Swaisland HC, Smith RP, Laight A, Kerr DJ, Ranson M, Wilder-Smith CH, Duvauchelle T (2005) Single-dose clinical pharmacokinetic studies of gefitinib. Clin Pharmacokinet 44(11):1165\u20131177. https:\/\/doi.org\/10.2165\/00003088-200544110-00004","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"32_CR45","doi-asserted-by":"publisher","first-page":"45","DOI":"10.5114\/wo.2021.103829","volume":"25","author":"KC Thandra","year":"2021","unstructured":"Thandra KC, Barsouk A, Saginala K, Aluru JS, Barsouk A (2021) Epidemiology of Lung Cancer Contemp Oncol (Pozn) 25(1):45\u201352. https:\/\/doi.org\/10.5114\/wo.2021.103829","journal-title":"Epidemiology of Lung Cancer Contemp Oncol (Pozn)"},{"issue":"1","key":"32_CR46","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2165\/00003088-199631010-00004","volume":"31","author":"I Walter-Sack","year":"1996","unstructured":"Walter-Sack I, Klotz U (1996) Influence of diet and nutritional status on drug metabolism. Clin Pharmacokinet 31(1):47\u201364. https:\/\/doi.org\/10.2165\/00003088-199631010-00004","journal-title":"Clin Pharmacokinet"},{"key":"32_CR47","doi-asserted-by":"publisher","first-page":"5467","DOI":"10.2147\/OTT.S194870","volume":"12","author":"ZY Xu","year":"2019","unstructured":"Xu ZY, Li JL (2019) Comparative review of drug-drug interactions with epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer. Onco Targets Ther 12:5467\u20135484. https:\/\/doi.org\/10.2147\/OTT.S194870","journal-title":"Onco Targets Ther"},{"key":"32_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.medidd.2020.100063","volume":"8","author":"H Yu","year":"2020","unstructured":"Yu H, Yang H, Shi E, Tang W (2020) Development and Clinical Application of Phosphorus-Containing Drugs. Med Drug Discov 8:100063. https:\/\/doi.org\/10.1016\/j.medidd.2020.100063","journal-title":"Med Drug Discov"}],"container-title":["Saudi Pharmaceutical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44446-025-00032-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s44446-025-00032-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44446-025-00032-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T08:39:42Z","timestamp":1762936782000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s44446-025-00032-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["32"],"URL":"https:\/\/doi.org\/10.1007\/s44446-025-00032-4","relation":{},"ISSN":["1319-0164","2213-7475"],"issn-type":[{"type":"print","value":"1319-0164"},{"type":"electronic","value":"2213-7475"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"3 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments followed the guidelines of the Ethical Committee for Performing Studies on Animals, King Saud University, Riyadh, Saudi Arabia, following protocol KSU-SE-19\u201313.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors affirm that no conflicting financial interests or personal relationships could have influenced the work described in this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declaration"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"37"}}